Further, mechanistic studies have indicated that SIX1, as an oncogene, is overexpressed in breast cancer [14], colorectal cancer [29], esophageal squamous cell carcinoma [30], and pancreatic cancer [31], and is associated with the development, progression, and prognosis of multiple tumors. Here, SIX1 is linked to pancreatic neoplasm.